Market Closed -
Other stock markets
|
After market 14:13:13 | |||
10.27 EUR | +3.01% | 10.26 | -0.10% |
05:06pm | Centogene, Evotec Discover New Molecule for Potential Gaucher Disease Treatment | MT |
05-06 | EVOTEC : Warburg Research reiterates its Buy rating | ZD |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.74% | 1.91B | |
+27.45% | 48.16B | |
-0.88% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.54% | 25.59B | |
-22.83% | 18.96B | |
+8.00% | 12.92B | |
+29.29% | 12.03B | |
-2.07% | 11.77B |
- Stock Market
- Equities
- EVT Stock
- News Evotec SE
- Evotec, Bristol-Myers Squibb Enter Exclusive Global License Agreement on Selected Neuroscience Programs